Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interleukin-6-174G>C gene promoter polymorphism and prognosis in patients with cancer.

Oncotarget - 4 Jul 2017

Zhai Kan, Yang Yong, Gao Zhi-Gang, Ding Jie

Abstract excerpt

Interleukin-6 (IL-6) is known to be involved in the pathogenesis of cancer progression. IL-6-174G>C polymorphism has shown several results in association studies. In this study, we evaluated the association the IL-6-174G>C polymorphism and overall survival (OS) of cancer using 17 eligible studies with 4,304 patients. Our meta-analysis indicated that IL-6-174G>C polymorphism is not associated with OS when assessed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Genetic Association Studies
Share to Interleukin-6

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasms

Share to Polymorphism, Single Nucleotide

Share to Prognosis

Share to Promoter Regions, Genetic

Share to Publication Bias

Source

Open in PubMed Open full text

Identifiers

PMID: 28548958
DOI: 10.18632/oncotarget.17771
PMCID: PMC5546496

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interleukin-6-174G>C gene promoter polymorphism and prognosis in patients with cancer.PMID 28548958Read ↗

Genetic variations in interleukin-6 polymorphism and the association with susceptibility and overall survival of osteosarcoma.Semantic proximity Read ↗

IL-6 -174G>C polymorphism and cancer risk: a meta-analysis involving 29,377 cases and 37,739 controls.Semantic proximity Read ↗

Associations of interleukin-6 gene polymorphisms with cancer risk: Evidence based on 49,408 cancer cases and 61,790 controls.Semantic proximity Read ↗

Statistical meta-analysis to investigate the association between the Interleukin-6 (IL-6) gene polymorphisms and cancer risk.Semantic proximity Read ↗

Association of the IL6 polymorphism rs1800796 with cancer risk: a meta-analysis.Semantic proximity Read ↗

Association of interleukin-6 (-174G>C) promoter polymorphism with risk of squamous cell esophageal cancer and tumor location: an exploratory study.Semantic proximity Read ↗

Association of the interleukin-6 gene -572G/C polymorphism with cancer risk: a meta-analysis.Semantic proximity Read ↗

Association of IL-6 -174G>C and -572G>C Polymorphisms with Susceptibility to Cervical Cancer and Ovarian Cancer.Semantic proximity Read ↗

IL-6 polymorphism in non-small cell lung cancer: a prognostic value?Semantic proximity Read ↗

The -174 G/C polymorphism in interleukin-6 (IL-6) promoter region is associated with serum IL-6 and carcinoembryonic antigen levels in patients with colorectal cancers in Taiwan.Semantic proximity Read ↗

Interleukin-6 as a Pan-Cancer Prognostic Inflammatory Biomarker: A Population-Based Study and Comprehensive Bioinformatics AnalysisSemantic proximity Read ↗

Association of IL-6 -174G>C (rs1800795) polymorphism with cervical cancer susceptibility.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.